Clearpoint Net Tangible Assets from 2010 to 2026
| CLPT Stock | USD 13.37 0.22 1.62% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 41.2 M | Current Value 43.3 M | Quarterly Volatility 19.7 M |
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 330 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 15.47. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
Clearpoint | Net Tangible Assets | Build AI portfolio with Clearpoint Stock |
The evolution of Net Tangible Assets for Clearpoint Neuro provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Clearpoint Neuro compares to historical norms and industry peers.
Latest Clearpoint Neuro's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Clearpoint Neuro over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Clearpoint Neuro's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Clearpoint Net Tangible Assets Regression Statistics
| Arithmetic Mean | 14,664,344 | |
| Coefficient Of Variation | 134.21 | |
| Mean Deviation | 17,958,886 | |
| Median | 2,024,000 | |
| Standard Deviation | 19,680,371 | |
| Sample Variance | 387.3T | |
| Range | 49.3M | |
| R-Value | 0.85 | |
| Mean Square Error | 116.3T | |
| R-Squared | 0.72 | |
| Significance | 0.000017 | |
| Slope | 3,303,386 | |
| Total Sum of Squares | 6197.1T |
Clearpoint Net Tangible Assets History
About Clearpoint Neuro Financial Statements
Clearpoint Neuro shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 41.2 M | 43.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.